Delegates and leaders representing the Commonwealth recently toured the CIPLA Quality Chemicals Industries Ltd (CIPLA QCIL) located in Luzira, a suburb of Kampala.
Their visit left them in awe of the facility’s impressive capability to manufacture vital medicines, which are commonly imported by African nations from overseas.
Notably, the CIPLA QCIL plant stands as one of only four pharmaceutical manufacturers in Africa that have received accreditation from the World Health Organization (WHO) to produce a range of essential medications, including anti-retroviral drugs and anti-malarial drugs.
The delegation led by Deputy Speaker, Thomas Tayebwa, toured the factory on Friday, 05 January 2024 and commended the Ugandan government for coming up with such a factory with medicines that are tailored to solve African problems.
“This is an eye opener to us that we can solve African problems using African solutions, we are very proud of Uganda” said Rt Hon. Ackson Tulia, Speaker, Parliament of Tanzania.
Tulia said she was sure her counterparts from other African countries will spread the ‘gospel’ on the work being done at CIPLA Quality chemicals, to other nations saying “the continent is ready to accommodate products from a fellow African nation”.
She was, however, concerned that the company supplies medicines to only 15 countries, moreover in Africa and urged government to consider the western market.
“I believe that Africa can also offer solutions to the rest of the world, we would like to see you cross the borders,” Tulia said.
The visiting Speakers, Tayebwa said, have the ability to influence their countries to consider importing from Uganda medicines such as Anti-retroviral drugs, anti-malarial drugs, and medicines to treat diabetes which are currently manufactured at CIPLA QCIL.
“These are the Speakers who preside over national budgets in their countries, they do oversight on how government is doing its work. We are urging them that from here they should go to their governments and ensure that medicines produced here should not be procured from Europe or Asia,” Tayebwa said.
Tayebwa remarked that some Speakers confessed that some of the companies from where their governments procure such essential medicines are not half of CIPLA QCIL in capacity.
He commended the company which he said was now both a national and continental pride.
“These are the people who saved countries like South Africa during the COVID-19 pandemic when Europe and America could not export to Africa, they stepped in and saved Af
